Robert Latkany1. 1. NY Medical College, Dry Eye Clinic NY Eye Ear Infirmary, New York, New York 10022, USA. relief@dryeyedoctor.com
Abstract
PURPOSE OF REVIEW: Until recently, the cause of dry eye syndrome was uncertain and the treatment was palliative. Since discovering that dry eyes are caused by inflammation, there has been an abundance of research focusing on anti-inflammatory therapies, other contributing causes, and better diagnostic testing. This review summarizes some of the interesting published research on ocular surface disease over the past year. RECENT FINDINGS: The definition of dry eye now highlights the omnipresent symptom of blurry vision. The re-evaluation of ocular surface staining, tear meniscus height, and visual change will allow for a better diagnosis and understanding of dry eyes. Punctal plugs, and oral and topical anti-inflammatory use will strengthen our arsenal against ocular surface disease. SUMMARY: Major progress has occurred in the past few years in gaining a better understanding of the etiology of dry eye syndrome, which will inevitably lead to more effective therapeutic options.
PURPOSE OF REVIEW: Until recently, the cause of dry eye syndrome was uncertain and the treatment was palliative. Since discovering that dry eyes are caused by inflammation, there has been an abundance of research focusing on anti-inflammatory therapies, other contributing causes, and better diagnostic testing. This review summarizes some of the interesting published research on ocular surface disease over the past year. RECENT FINDINGS: The definition of dry eye now highlights the omnipresent symptom of blurry vision. The re-evaluation of ocular surface staining, tear meniscus height, and visual change will allow for a better diagnosis and understanding of dry eyes. Punctal plugs, and oral and topical anti-inflammatory use will strengthen our arsenal against ocular surface disease. SUMMARY: Major progress has occurred in the past few years in gaining a better understanding of the etiology of dry eye syndrome, which will inevitably lead to more effective therapeutic options.
Authors: Isaac Avni; Hanna J Garzozi; Irina S Barequet; Fanni Segev; David Varssano; Gil Sartani; Noa Chetrit; Erez Bakshi; David Zadok; Oren Tomkins; Gilad Litvin; Kenneth A Jacobson; Sari Fishman; Zivit Harpaz; Motti Farbstein; Sara Bar Yehuda; Michael H Silverman; William D Kerns; David R Bristol; Ilan Cohn; Pnina Fishman Journal: Ophthalmology Date: 2010-03-20 Impact factor: 12.079